Cargando…
Advances and challenges of CAR T therapy and suitability of animal models (Review)
Chimeric antigen receptors (CARs) recently gained momentum in cancer treatment due to their ability to promote T-cell mediated responses to a specific tumor-associated antigen. CARs are part of the adoptive cell transfer (ACT) strategies that utilize patients' T lymphocytes, genetically enginee...
Autores principales: | Ramos-Cardona, Xavier E., Luo, Weichuan, Mohammed, Sulma I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353808/ https://www.ncbi.nlm.nih.gov/pubmed/35949897 http://dx.doi.org/10.3892/mco.2022.2567 |
Ejemplares similares
-
Motor Cars for Doctors: Cars Suitable for Practitioners
Publicado: (1906) -
Repolarization of Tumor-Infiltrating Myeloid Cells for Augmentation of CAR T Cell Therapies
por: Luo, Weichuan, et al.
Publicado: (2022) -
Applying a clinical lens to animal models of CAR-T cell therapies
por: Duncan, Brynn B., et al.
Publicado: (2022) -
Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Kulemzin, Sergey, et al.
Publicado: (2021) -
Advancements in CAR-NK therapy: lessons to be learned from CAR-T therapy
por: Kilgour, Marisa K., et al.
Publicado: (2023)